Ipg Photonics earnings release, August 4, 2026
IPG PHOTONICS ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS
Improving Industrial Demand and Continued Focus on Strategic Initiatives Drive Results
Managing Costs and Driving Gross Margin Improvement
MARLBOROUGH, Mass. – August 4, 2026 -
IPG Photonics Corporation
(NASDAQ: IPGP) today reported financial results for the second quarter ended June 30, 2026.
*Adjusted gross margin, adjusted EBITDA and adjusted earnings per diluted share include non-GAAP adjustments. A reconciliation from GAAP to non-GAAP metrics is provided in this earnings release.
NM - not meaningful.
Management Comments
“We delivered our third consecutive quarter of double-digit year-over-year revenue growth, with revenue above the midpoint of our guidance and adjusted gross margin and adjusted EPS above our expectations,” said Dr. Mark Gitin, Chief Executive Officer of IPG Photonics. “Industrial Solutions generated strong revenue growth, supported by robust demand and disciplined execution across different markets and applications, particularly in battery manufacturing. Advanced Solutions revenue benefited from our continued focus on key strategic initiatives, resulting in strong sales growth in semiconductor applications. We see continued interest in our CROSSBOW™ directed energy system. Additionally, our recently announced acquisition of Lumibird Medical will further accelerate our strategic expansion into attractive medical markets in Advanced Solutions.”
Financial Highlights¹
Exhibit 99.1
Second quarter revenue of $279 million increased 11% year over year, driven by 16% growth in Industrial Solutions. Changes in foreign exchange rates increased revenue by approximately 2%. Industrial Solutions sales, accounting for 85% of total revenue, were driven by growth in welding, marking, cleaning and additive manufacturing applications. Advanced Solutions sales decreased 9% year over year due to lower revenue in micromachining and defense applications, partially offset by increased sales in semiconductor applications. Emerging growth products accounted for 58% of total revenue, up from 53% in the prior quarter. By region, sales increased 19% in Asia and 5% in Europe, while decreasing 2% in North America on a year-over-year basis.
GAAP gross margin of 40.4% and adjusted gross margin of 40.7% increased year over year, driven by lower product costs, lower inventory provisions, and $4.7 million in tariff refunds recorded in the period.
Adjusted EBITDA was $48.5 million and adjusted earnings per diluted share (EPS) was $0.58 in the second quarter. During the second quarter, IPG generated $37.8 million in cash flow from operations and spent $20.7 million on capital expenditures.
Business Outlook and Financial Guidance
“Our book-to-bill remained above one in the second quarter, pointing to ongoing robust demand for our solutions and the team's focused execution of our growth strategy. Our technological leadership in lasers and photonics and proven track record of solving challenging customer problems continues to create compelling opportunities for laser adoption in attractive markets and applications. Supported by the One IPG Operating Model, which drives operational excellence, and an innovation engine, we are unlocking areas of significant additional and lasting value for our customers and stockholders,” concluded Dr. Gitin.
For the third quarter of 2026, IPG expects revenue of $265 million to $295 million, adjusted gross margin between 37.5% and 40.5% and adjusted operating expenses of $92 million to $95 million. IPG anticipates delivering adjusted earnings per diluted share in the range of $0.30 to $0.60 and adjusted EBITDA in the range of $35 million to $51 million.
As discussed in more detail in the "Safe Harbor" passage of this news release, actual results may differ from this guidance due to various factors including, but not limited to, trade policy changes and trade restrictions, product demand, order cancellations and delays, competition, tariffs and retaliatory tariffs, currency fluctuations and general economic conditions. The current uncertainty related to the trade environment and tariff policies increases the risks to the outlook that we have provided. This guidance is based upon current market conditions and expectations and is subject to the risks outlined in the Company's reports filed with the SEC and assumes exchange rates relative to the U.S. dollar of euro 0.88, Japanese yen 162 and Chinese yuan 6.81, respectively.
Supplemental Financial Information
Additional supplemental financial information is provided in the unaudited Financial Data Workbook and Second Quarter 2026 Earnings Call Presentation available on the investor relations section of the Company's website at investor.ipgphotonics.com.
Conference Call Reminder
The Company will hold a conference call today, August 4, 2026 at 10:00 am ET. To access the call, please dial 877-407-6184 in the US or 201-389-0877 internationally. A live webcast of the call will also be available and archived on the investor relations section of the Company's website at investor.ipgphotonics.com.
Contact
Eugene Fedotoff
Senior Director, Investor Relations
IPG Photonics Corporation
508-597-4713 efedotoff@ipgphotonics.com
About IPG Photonics Corporation
Innovation is at the heart of IPG Photonics. As a global leader in laser technology, we apply light to transform the world. From manufacturing to medical and beyond, our breakthrough laser solutions power our customers’ success and expand what's possible. Discover more at www.ipgphotonics.com.²
Exhibit 99.1
Financial statements
Income Statement
Three Months Ended June 30, — (NASDAQ: IPGP) today reported financial results for the second quarter ended June 30, 2026. (In millions, except per share data and percentages)
| Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Three Months Ended June 30, – Change | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 | Six Months Ended June 30, – Change | ||
|---|---|---|---|---|---|---|---|
| Revenue | 278.6 | 250.7 | 11 | 544.1 | 478.5 | 14 | |
| Gross margin | 40.4% | 37.3% | 39.0% | 38.3% | |||
| Operating income (loss) | 4.5 | 0.1 | NM | -3.2 | 1.9 | NM | |
| Operating margin | 1.6% | -0.6% | 0.4% | ||||
| Net income | 5.2 | 6.6 | -21 | 6.8 | 10.4 | -35 | |
| Earnings per diluted share | 0.12 | 0.16 | -25 | 0.16 | 0.24 | -33 | |
| Non-GAAP Measures* | Adjusted gross margin | 40.7% | 37.8% | 39.3% | 38.9% | ||
| Non-GAAP Measures* | Adjusted EBITDA | 48.5 | 31.5 | 54 | 83.7 | 64.2 | 30 |
| Non-GAAP Measures* | Adjusted earnings per diluted share | 0.58 | 0.3 | 93 | 0.87 | 0.61 | 43 |
Income Statement
Three Months Ended June 30, — (UNAUDITED) (In thousands, except per share data)
| Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 | ||
|---|---|---|---|---|---|
| Net sales | 278,580 | 250,721 | 544,077 | 478,514 | |
| Cost of sales | 166,056 | 157,148 | 332,054 | 295,129 | |
| Gross profit | 112,524 | 93,573 | 212,023 | 183,385 | |
| Operating expenses: | Sales and marketing | 23,818 | 25,552 | 48,352 | 49,982 |
| Operating expenses: | Research and development | 31,004 | 29,937 | 64,313 | 58,273 |
| Operating expenses: | General and administrative | 36,545 | 34,882 | 72,637 | 67,690 |
| Operating expenses: | Settlement of litigation matters | -166 | 13,334 | ||
| Operating expenses: | Impairment charges | 17,574 | 17,574 | ||
| Operating expenses: | (Gain) loss on foreign exchange | -782 | 3,098 | -982 | 5,509 |
| Operating expenses: | Total operating expenses | 107,993 | 93,469 | 215,228 | 181,454 |
| Operating expenses: | Operating income (loss) | 4,531 | 104 | -3,205 | 1,931 |
| Other income, net: | Interest income, net | 7,110 | 8,001 | 14,032 | 15,445 |
| Other income, net: | Other income, net | 900 | 166 | 2,733 | 1,510 |
| Other income, net: | Total other income | 8,010 | 8,167 | 16,765 | 16,955 |
| Other income, net: | Income before provision for income taxes | 12,541 | 8,271 | 13,560 | 18,886 |
| Other income, net: | Provision for income taxes | 7,299 | 1,666 | 6,734 | 8,523 |
| Other income, net: | Net income | 5,242 | 6,605 | 6,826 | 10,363 |
| Net income per common share: | Basic | 0.12 | 0.16 | 0.16 | 0.24 |
| Net income per common share: | Diluted | 0.12 | 0.16 | 0.16 | 0.24 |
| Weighted average common shares outstanding: | Basic | 42,470 | 42,481 | 42,358 | 42,543 |
| Weighted average common shares outstanding: | Diluted | 42,913 | 42,577 | 42,914 | 42,720 |
Income Statement
Three Months Ended June 30, — Reconciliation of Gross Profit to Adjusted Gross Profit, Adjusted Gross Margin (in thousands, except percentages)
| Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 | |
|---|---|---|---|---|
| Gross profit | 112,524 | 93,573 | 212,023 | 183,385 |
| Gross margin | 40.4% | 37.3% | 39.0% | 38.3% |
| Amortization of acquisition-related intangibles | 788 | 1,061 | 1,640 | 2,077 |
| Acquisition and integration charges | 260 | 482 | ||
| Adjusted gross profit | 113,312 | 94,894 | 213,663 | 185,944 |
| Adjusted gross margin | 40.7% | 37.8% | 39.3% | 38.9% |
Income Statement
Three Months Ended June 30, — Reconciliation of Operating income (loss) to Adjusted Operating Income (in thousands)
| Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 | |
|---|---|---|---|---|
| Operating income (loss) | 4,531 | 104 | -3,205 | 1,931 |
| Amortization of acquisition-related intangibles | 2,021 | 2,594 | 4,110 | 5,096 |
| Restructuring charges | 285 | 351 | ||
| Acquisition and integration charges | -70 | 1,068 | 836 | 2,059 |
| Impairment charges | 17,574 | 17,574 | ||
| Settlement and fees of litigation matters | 307 | 14,435 | ||
| (Gain) loss on foreign exchange | -782 | 3,098 | -982 | 5,509 |
| Adjusted operating income | 23,866 | 6,864 | 33,119 | 14,595 |
Income Statement
Three Months Ended June 30, — Reconciliation of Net income to Adjusted EBITDA (in thousands)
| Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 | |
|---|---|---|---|---|
| Net income | 5,242 | 6,605 | 6,826 | 10,363 |
| Interest income, net | -7,110 | -8,001 | -14,032 | -15,445 |
| Provision for income taxes | 7,299 | 1,666 | 6,734 | 8,523 |
| Depreciation | 12,714 | 12,172 | 25,461 | 23,728 |
| Amortization | 2,809 | 3,654 | 5,954 | 7,439 |
| EBITDA | 20,954 | 16,096 | 30,943 | 34,608 |
| Impairment charges | 17,574 | 17,574 | ||
| Stock based compensation | 10,234 | 11,287 | 20,575 | 22,054 |
| Restructuring charges | 285 | 351 | ||
| Acquisition and integration charges | -70 | 1,068 | 836 | 2,059 |
| Settlement and fees of litigation matters | 307 | 14,435 | ||
| (Gain) loss on foreign exchange | -782 | 3,098 | -982 | 5,509 |
| Adjusted EBITDA | 48,502 | 31,549 | 83,732 | 64,230 |
Income Statement
Three Months Ended June 30, — Reconciliation of GAAP to Non-GAAP Net Income, and GAAP to Non-GAAP Net Income per Share, Diluted (in thousands, except per share data)
| Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 | |
|---|---|---|---|---|
| Net income | 5,242 | 6,605 | 6,826 | 10,363 |
| Impairment charges | 17,574 | 17,574 | ||
| Amortization of acquisition-related intangibles | 2,021 | 2,594 | 4,110 | 5,096 |
| Restructuring charges | 285 | 351 | ||
| Acquisition and integration charges | -70 | 1,068 | 836 | 2,059 |
| Settlement and fees of litigation matters | 307 | 14,435 | ||
| (Gain) loss on foreign exchange | -782 | 3,098 | -982 | 5,509 |
| Certain discrete tax items | 284 | 275 | -835 | 4,889 |
Balance Sheet
December 31, — (UNAUDITED) (In thousands, except share and per share data)
| June 30, – 2026 – ASSETS | December 31, – 2025 – ASSETS | ||
|---|---|---|---|
| Current assets: | Cash and cash equivalents | 399,225 | 403,790 |
| Current assets: | Short-term investments | 472,094 | 435,538 |
| Current assets: | Accounts receivable, net | 181,960 | 181,734 |
| Current assets: | Inventories | 330,801 | 313,416 |
| Current assets: | Prepaid income taxes | 39,423 | 43,196 |
| Current assets: | Prepaid expenses and other current assets | 55,269 | 45,766 |
| Current assets: | Total current assets | 1,478,772 | 1,423,440 |
| Current assets: | Long-term investments | 32,693 | 76,533 |
| Current assets: | Deferred income taxes, net | 116,831 | 123,889 |
| Current assets: | Goodwill | 70,480 | 71,735 |
| Current assets: | Intangible assets, net | 44,893 | 49,933 |
| Current assets: | Property, plant and equipment, net | 641,916 | 637,516 |
| Current assets: | Other assets | 38,982 | 41,234 |
| Current assets: | Total assets | 2,424,567 | 2,424,280 |
| Current assets: | LIABILITIES AND EQUITY | LIABILITIES AND EQUITY | LIABILITIES AND EQUITY |
| Current liabilities: | Accounts payable | 42,879 | 39,288 |
| Current liabilities: | Accrued expenses and other current liabilities | 192,458 | 184,849 |
| Current liabilities: | Income taxes payable | 3,986 | 9,900 |
| Current liabilities: | Total current liabilities | 239,323 | 234,037 |
| Current liabilities: | Other long-term liabilities and deferred income taxes | 58,066 | 62,113 |
| Current liabilities: | Total liabilities | 297,389 | 296,150 |
| Stockholders' equity: | Common stock, $0.0001 par value, 175,000,000 shares authorized; 57,371,639 and 42,533,767 shares issued and outstanding, respectively, at June 30, 2026; 56,964,939 and 42,127,067 and shares issued and outstanding, respectively, at December 31, 2025. | 6 | 6 |
| Stockholders' equity: | Treasury stock, at cost, 14,837,872 shares held at June 30, 2026 and December 31, 2025, respectively. | -1,555,629 | -1,555,629 |
| Stockholders' equity: | Additional paid-in capital | 1,086,949 | 1,077,172 |
| Stockholders' equity: | Retained earnings | 2,651,790 | 2,644,964 |
| Stockholders' equity: | Accumulated other comprehensive loss | -55,938 | -38,383 |
| Stockholders' equity: | Total stockholders' equity | 2,127,178 | 2,128,130 |
| Stockholders' equity: | Total liabilities and stockholders' equity | 2,424,567 | 2,424,280 |
Cash Flow
Six Months Ended June 30, — (UNAUDITED) (in thousands)
| Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 | ||
|---|---|---|---|
| Cash flows from operating activities: | Net income | 6,826 | 10,363 |
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | Depreciation and amortization | 31,415 | 31,167 |
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | Impairment charges | 17,574 | |
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | Provisions for inventory, warranty & bad debt | 20,556 | 22,080 |
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | Other | 23,366 | 17,162 |
| Changes in assets and liabilities that (used) provided cash: | Accounts receivable and accounts payable | 3,811 | -14,061 |
| Changes in assets and liabilities that (used) provided cash: | Inventories | -42,086 | -23,837 |
| Changes in assets and liabilities that (used) provided cash: | Other | -29,133 | -31,645 |
| Changes in assets and liabilities that (used) provided cash: | Net cash provided by operating activities | 32,329 | 11,229 |
| Cash flows from investing activities: | Purchases of and deposits on property, plant and equipment | -37,024 | -40,176 |
| Cash flows from investing activities: | Proceeds from sales of property, plant and equipment | 1,006 | 563 |
| Cash flows from investing activities: | Purchases of investments | -286,742 | -579,814 |
| Cash flows from investing activities: | Proceeds from maturities of investments | 297,335 | 357,859 |
| Cash flows from investing activities: | Deposit received from buyer for assets held for sale | 2,000 | |
| Cash flows from investing activities: | Other | 85 | 52 |
| Cash flows from investing activities: | Net cash used in investing activities | -23,340 | -261,516 |
| Cash flows from financing activities: | Payments for taxes related to net share settlement of equity awards less proceeds from issuance of common stock under employee stock option and purchase plans | -10,755 | -4,253 |
| Cash flows from financing activities: | Purchase of treasury stock net of excise tax, at cost | -30,204 | |
| Cash flows from financing activities: | Net cash used in financing activities | -10,755 | -34,457 |
| Cash flows from financing activities: | Effect of changes in exchange rates on cash, cash equivalents and cash held for sale | -2,245 | 23,888 |
| Cash flows from financing activities: | Net decrease in cash, cash equivalents and cash held for sale | -4,011 | -260,856 |
| Cash flows from financing activities: | Cash and cash equivalents — Beginning of period | 403,790 | 620,040 |
| Cash flows from financing activities: | Cash, cash equivalents and cash held for sale — End of period | 399,779 | 359,184 |
| Supplemental disclosures of cash flow information: | Cash paid for interest | 7 | 8 |
| Supplemental disclosures of cash flow information: | Cash paid for income taxes, net of refunds | 3,408 | 32,918 |
Full release
Safe Harbor Statement... (truncated)e statements related to acquisition of Lumibird Medical further accelerating our strategic expansion into attractive medical markets in Advanced Solutions, ongoing robust demand for our solutions and the team’s focused execution of our growth strategy, our technological leadership in lasers and photonics and proven track record of solving challenging customer problems continuing to create compelling opportunities for laser adoption in attractive markets and applications, the One IPG Operating Model driving operational excellence, and an innovation engine, unlocking areas of significant additional and lasting value for our customers and stockholders, and statements related to share repurchases, revenue, adjusted gross margin and operating expenses outlook, adjusted earnings per diluted share and adjusted EBITDA guidance, including the expected impact of tariffs, and the impact of the U.S. dollar on our guidance for the third quarter of 2026. Factors that could cause actual results to differ materially include risks and uncertainties, including risks associated with the strength or weakness of business conditions in industries and geographic markets that IPG serves, particularly the effect of downturns in the markets IPG serves; uncertainties and adverse changes in the general economic conditions of markets; inability to manage risks associated with international customers and operations; changes in trade controls and tariff policies; IPG's ability to penetrate new applications for fiber lasers and increase market share; the rate of acceptance and penetration of IPG's products; foreign currency fluctuations; high levels of fixed costs from IPG's vertical integration; the appropriateness of IPG's manufacturing capacity for the level of demand; competitive factors, including declining average selling prices; the effect of acquisitions and investments; inventory write-downs; asset impairment charges; intellectual property infringement claims and litigation; interruption in supply of key components; manufacturing risks; government regulations and trade sanctions; and other risks identified in IPG's SEC filings. Readers are encouraged to refer to the risk factors described in IPG's Annual Report on Form 10-K (filed with the SEC on February 23, 2026) and IPG's reports filed with the SEC, as applicable. Actual results, events and performance may differ materially. Readers are cautioned not to rely on the forward-looking statements, which speak only as of the date hereof. IPG undertakes no obligation to update the forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.³
Exhibit 99.1